MARIA LUIZA NOGUEIRA DIAS GENTA

(Fonte: Lattes)
Índice h a partir de 2011
7
Projetos de Pesquisa
Unidades Organizacionais
Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas, Faculdade de Medicina - Médico
Instituto Central, Hospital das Clínicas, Faculdade de Medicina - Médico
LIM/58 - Laboratório de Ginecologia Estrutural e Molecular, Hospital das Clínicas, Faculdade de Medicina

Resultados de Busca

Agora exibindo 1 - 10 de 18
  • conferenceObject
    RETROSPECTIVE ANALYSIS OF RADICAL HYSTERECTOMY IN A SINGLE BRAZILIAN CANCER CENTER
    (2016) CARVALHO, J. P. Mancusi de; GENTA, M. L. Nogueira Dias; SADALLA, J. C.; NOBREGA, F. de Souza; ORTOLAN, N. Macerox; CARVALHO, J. Paula
  • conferenceObject
    In Bag Morcellation: details and logistics of the technique
    (2016) FERNANDES, R.; ARAUJO, M.; SILVA, A. Silva e; CARVALHO, P. Mancusi de; ANTON, C.; GENTA, M. L. Nogueira Dias; RIBEIRO JR., A. Dias; SAMPAIO, D.; MIGLINO, G.; SADALLA, J. C.; CARVALHO, J. Paula
  • conferenceObject
    BORDERLINE OVARIAN TUMORS-10 YEARS SINGLE CENTER EXPERIENCE
    (2019) FERNANDES, R.; ANTON, C.; SILVA, A. Silva e; CARVALHO, J. P. Mancusi; ARAUJO, M.; GENTA, M. L. Dias; SAMPAIO, D.; MIGLINO, G.; DIAS JR., A.; SADALLA, J. C.; CARVALHO, J. Paula
  • article 17 Citação(ões) na Scopus
    Cardiophrenic lymph node resection in cytoreduction for primary advanced or recurrent epithelial ovarian carcinoma: a cohort study
    (2019) LOPES, Andre; COSTA, Ronaldo Lucio Rangel; PAULA, Raphael di; ANTON, Cristina; CALHEIROS, Ytauan; SARTORELLI, Vivian; KANASHIRO, Yara Mitie; LIMA, Joao Alves de; YAMADA, Alayne; PINTO, Gabriel Lowndes de S.; VIANNA, Maria Regina; GENTA, Maria Luiza Nogueira Dias; RIBEIRO, Ulysses; SANTOS, Marcelo Oliveira dos
    Objectives To evaluate the clinical outcomes of epithelial ovarian carcinoma patients who underwent cardiophrenic lymph node resection. Methods We retrospectively reviewed the records of all surgically treated patients with advanced epithelial ovarian carcinoma (stages IIIC-IV) who underwent cardiophrenic lymph node resection between 2002 and 2018. Only those in whom cardiophrenic lymph node involvement was the only detectable extra-abdominal disease were included. Patients with suspected cardiophrenic lymph node metastasis on staging images underwent a transdiaphragmatic incision to access the para-cardiac space after complete abdominal cytoreduction achievement. Data on disease-free survival, overall survival, and surgical procedures performed concurrently with cardiophrenic lymph node resection were collected. Results Of the total 456 patients, 29 underwent cardiophrenic lymph node resection; of these, 24 patients met the inclusion criteria. Twenty-two, one, and one patients had high grade serous epithelial ovarian carcinoma, low grade epithelial ovarian carcinoma, and ovarian carcinosarcoma, respectively. Ten patients had recurrent disease (recurrence group). Fourteen patients underwent cytoreduction during primary treatment (primary debulking group); four underwent cytoreduction after neoadjuvant chemotherapy. Cardiophrenic lymph node resection was performed on the right side in 19 patients, left side in three, and bilaterally in two. The average procedural duration was 28 minutes, with minimal blood loss and no severe complications. Twenty-one patients had cardiophrenic lymph node positivity. The median disease-free intervals were 17 and 12 months in the recurrent and primary debulking surgery groups, respectively. The mediastinum was the first recurrence site in 10 patients. Five patients developed brain metastases. Five patients had an overall survival beyond 50 months. Conclusions Although rare, the cardiophrenic lymph nodes may be a site of metastasis of ovarian cancer. Although their presence might indicate future recurrence, some patients may achieve long-term survival. Resection should be considered in cases of suspicious involvement to confirm extra-abdominal disease and achieve complete cytoreduction.
  • conferenceObject
    Human papillomavirus 16 is an independent predictor of better survival among patients with early cervical cancer
    (2016) GENTA, M. L. N. D.; LEVI, J. E.; MARTINS, T. R.; SADALLA, J. C.; LOPEZ, R. V. M.; CARVALHO, J. P. M.; CARVALHO, J. P.
  • conferenceObject
    TOXICITY PROFILE IN PATIENTS SUBMITTED TO NEW STRATEGY FOR THE TREATMENT OF VULVAR CANCER EMPLOYING SENTINEL LYMPH NODE SCINTIGRAPHY, SURGERY, CHEMOTHERAPY, AND RADIOTHERAPY
    (2019) DIAS- JR., A.; NAJAS, G.; GABRIELLI, F.; CARVALHO, H.; MIGLINO, G.; FARIA, M. B. Sartor; ARAUJO, M.; GENTA, M. L. Nogueira Dias; CARVALHO, J. Paula; BARACAT, E. Chada
  • conferenceObject
    NEW APPROACH TO DEFINE PATIENTS WITH LOW RISK LYMPH NODE METASTASIS WITH ENDOMETRIAL CANCER
    (2015) ANTON, C.; FAVERO, G. M.; SILVA, A. S.; MANCUSI, J. P.; ARAUJO, M. P.; SUAREZ, G. M.; GENTA, M. L. D.; PIATO, D. S. A. M.; DIAS JR., A. R.; FERNANDES, R. P.; SADALLA, J. C.; CARVALHO, J. P.
  • article 0 Citação(ões) na Scopus
    Autologous heterotopic fresh ovarian graft: technique description
    (2023) BERTOLAZZI, Marilia Albanezi; FERNANDES, Rodrigo Pinto; GENTA, Maria Luiza Nogueira Dias; BARACAT, Edmund Chada; CARVALHO, Jesus Paula
  • conferenceObject
    LAPAROSCOPIC PARAORTIC LYMPHDENECTOMY BY ANATOMICAL HIGHLIGHTED LANDMARKS
    (2019) FERNANDES, R.; ALEXANDRE, S. E. S.; ANTON, C.; CARVALHO, J. P. Mancusi; ARAUJO, M.; GENTA, M. L. Dias; SAMPAIO, D.; MIGLINO, G.; DIAS JR., A.; SADALLA, J. C.; CARVALHO, J. P.
  • conferenceObject
    OVARIAN TUMOR IN PATIENTS WITH PREVIOUS GASTROINTESTINAL CARCINOMA
    (2019) NOBREGA, F.; ANTON, C.; SILVA, A. Lopes de Farias e; GENTA, M. L. Nogueira Dias; CARVALHO, J. P. Mancusi de; CARVALHO, J. Paula